Protection against reinfection with D614- or G614-SARS-CoV-2 isolates in golden Syrian hamster

References

• WHOWHO Coronavirus Disease (COVID-19) Dashboard | WHO Coronavirus Disease (COVID-19) Dashboard. Who. 2020. https://covid19.who.int/.Accessed 14 October 14, 2020.
   Google Scholar
• Ju B, Zhang Q, Ge J, et al. Human neutralizing antibodies elicited by SARS-CoV-2 infection. Nature. 2020;584:115–119.
   PubMed Web of Science ®Google Scholar
• Wajnberg A, Amanat F, Firpo A, et al. Robust neutralizing antibodies to SARS-CoV-2 infection persist for months. Science. 2020;370(6521):1227–1230.
   PubMed Web of Science ®Google Scholar
• Seow J, Graham C, Merrick B et al. Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans. Nat Microbiol 2020: 1–10.
   Google Scholar
• Long QX, Tang XJ, Shi QL, et al. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat Med. 2020;26:1200–1204.
   PubMed Web of Science ®Google Scholar
• To KK-W, Hung IF-N, Ip JD, et al. Coronavirus Disease 2019 (COVID-19) Re-infection by a Phylogenetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2 strain confirmed by whole genome sequencing. Clin Infect Dis. 2020: ciaa1275.
   Google Scholar
• Prado-Vivar B, Becerra-Wong M, Guadalupe JJ et al. COVID-19 Re-Infection by a Phylogenetically Distinct SARS-CoV-2 variant, first confirmed event in South America. SSRN Electronic Journal 2020. https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3686174
   Google Scholar
• Van Elslande J, Vermeersch P, Vandervoort K, et al. Symptomatic severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) reinfection by a Phylogenetically Distinct strain. Clin Infect Dis. 2020: ciaa1330, doi:https://doi.org/10.1093/cid/ciaa1330.
   Google Scholar
• Tillett RL, Sevinsky JR, Hartley PD et al. Genomic evidence for reinfection with SARS-CoV-2: a case study. Lancet Infect Dis 2021;21(1):52–58.
   PubMed Web of Science ®Google Scholar
• Gupta V, Bhoyar RC, Jain A et al. Asymptomatic reinfection in 2 healthcare workers from India with genetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2. Clin Infect Dis 2020.
   Web of Science ®Google Scholar
• Raddad LJA, Chemaitelly H, Malek JA et al. Assessment of the risk of SARS-CoV-2 reinfection in an intense re-exposure setting. Clin Infect Dis. 2020;ciaa1846.
   Web of Science ®Google Scholar
• Brocato RL, Principe LM, Kim RK, et al. Disruption of adaptive immunity enhances Disease in SARS-CoV-2-infected Syrian hamsters. J Virol. 2020;94; doi:https://doi.org/10.1128/JVI.01683-20.
   Google Scholar
• Chandrashekar A, Liu J, Martinot AJ, et al. SARS-CoV-2 infection protects against rechallenge in rhesus macaques. Science. 2020;369(6505):812–817.
   PubMed Web of Science ®Google Scholar
• Deng W, Bao L, Liu J, et al. Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques. Science. 2020;369:818–823.
   PubMed Web of Science ®Google Scholar
• Di JR, Liu MQ, Chen Y, et al. Pathogenesis of SARS-CoV-2 in transgenic mice expressing human angiotensin-converting enzyme 2. Cell. 2020;182:50–58.e8.
   Web of Science ®Google Scholar
• Bosco-Lauth AM, Hartwig AE, Porter SM, et al. Experimental infection of domestic dogs and cats with SARS-CoV-2: pathogenesis, transmission, and response to reexposure in cats. Proc Natl Acad Sci. 2020;117(42):26382–26388.
   PubMed Web of Science ®Google Scholar
• Imai M, Iwatsuki-Horimoto K, Hatta M et al. Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development. Proc Natl Acad Sci U S A 2020;117(28):16587–16595.
   PubMed Web of Science ®Google Scholar
• Sia SF, Yan LM, Chin AWH, et al. Pathogenesis and transmission of SARS-CoV-2 in golden hamsters. Nature. 2020;583:1–5.
   Web of Science ®Google Scholar
• Muñoz-Fontela C, Dowling WE, Funnell SGP, et al. Animal models for COVID-19. Nature. 2020;586:509–515.
   PubMed Web of Science ®Google Scholar
• Bertzbach LD, Dietert K, Abdelgawad A et al. Age-dependent progression of SARS-CoV-2 infection in Syrian hamsters. Viruses 2020;12(7):779.
   Web of Science ®Google Scholar
• Yurkovetskiy L, Wang X, Pascal KE, et al. Structural and functional analysis of the D614G SARS-CoV-2 Spike protein variant. Cell. 2020;183:739–751.e8.
   PubMed Web of Science ®Google Scholar
• Korber B, Fischer WM, Gnanakaran S, et al. Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus. Cell. 2020;182:812–827.e19.
   PubMed Web of Science ®Google Scholar
• Hou YJ, Chiba S, Halfmann P et al. SARS-CoV-2 D614G variant exhibits enhanced replication ex vivo and earlier 1 transmission in vivo. Science 2020;370(6523):1464–1468.
   PubMed Web of Science ®Google Scholar
• Hu J, He CL, Gao Q et al. The D614G mutation of SARS-CoV-2 spike protein enhances viral infectivity. doi: https://doi.org/10.1101/2020.06.20.161323
   Google Scholar
• Plante JA, Liu Y, Liu J, et al. Spike mutation D614G alters SARS-CoV-2 fitness. Nature. 2020;592(7852):116–121.
   Web of Science ®Google Scholar
• Rockx B, Kuiken T, Herfst S et al. Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model. Science 2020;368:1012–1015.
   PubMed Web of Science ®Google Scholar
• Corman VM, Landt O, Kaiser M, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Eurosurveillance; 2020;25:2000045.
   Web of Science ®Google Scholar
• Wölfel R, Corman VM, Guggemos W, et al. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020;581:465–469.
   PubMed Web of Science ®Google Scholar
• Vergara-Alert J, van den Brand JMA, Widagdo W, et al. Livestock susceptibility to infection with Middle East respiratory syndrome coronavirus. Emerg Infect Dis. 2017;23:232–240.
   PubMed Web of Science ®Google Scholar
• Rodon J, Okba NMA, Te N, et al. Blocking transmission of Middle East respiratory syndrome coronavirus (MERS-CoV) in llamas by vaccination with a recombinant spike protein. Emerg Microbes Infect. 2019;8:1593–1603.
   PubMed Web of Science ®Google Scholar
• van Doremalen N, Lambe T, Spencer A et al. Chadox1 nCoV-19 vaccination prevents SARS-CoV-2 pneumonia in rhesus macaques. Nature. 2021;586:578–582.
   Web of Science ®Google Scholar
• Chen Y, Tong X, Li Y, et al. A comprehensive, longitudinal analysis of humoral responses specific to four recombinant antigens of SARS-CoV-2 in severe and non-severe COVID-19 patients. PLOS Pathog. 2020;16:e1008796.
   Web of Science ®Google Scholar
• Butler SE, Crowley AR, Natarajan H et al. Features and functions of systemic and mucosal humoral immunity Among SARS-CoV-2 convalescent individuals. Front Immunol 2021;11:618685.
   Web of Science ®Google Scholar
• Cervia C, Nilsson J, Zurbuchen Y et al. Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19. J Allergy Clin Immunol. 2021;147(2):545–557.
   Web of Science ®Google Scholar
• Woolsey C, Borisevich V, Prasad AN et al. Establishment of an African green monkey model for COVID-19 and protection against re-infection. Nat Immunol. 2021;22(1):86–98.
   PubMed Web of Science ®Google Scholar
• Cao WC, Liu W, Zhang PH, et al. Disappearance of antibodies to SARS-associated Coronavirus after recovery. N. Engl. J. Med. 2007;357:1162–1163.
   PubMed Web of Science ®Google Scholar
• Grifoni A, Weiskopf D, Ramirez SI, et al. Targets of T cell responses to SARS-CoV-2 Coronavirus in humans with COVID-19 Disease and unexposed individuals. Cell. 2020;181:1489–1501.e15.
   PubMed Web of Science ®Google Scholar
• Braun J, Loyal L, Frentsch M, et al. SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19. Nature. 2020;587:270–274.
   PubMed Web of Science ®Google Scholar
• Le Bert N, Tan AT, Kunasegaran K, et al. SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls. Nature. 2020;584:457–462.
   PubMed Web of Science ®Google Scholar
• Galanti M, Shaman J. Direct observation of repeated infections with endemic coronaviruses. J Infect Dis. 2020;XX:1–7.
   Google Scholar
• Callow KA, Parry HF, Sergeant M, et al. The time course of the immune response to experimental coronavirus infection of man. Epidemiol Infect. 1990;105:435–446.
   PubMed Web of Science ®Google Scholar